Sc. Clifford et al., ALTERATIONS IN EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) GENE IN HIGH-GRADE TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, British Journal of Cancer, 73(5), 1996, pp. 659-666
Expression of the MRP gene has been demonstrated in vitro to be a caus
al factor in non-P-glycoprotein-mediated multidrug resistance, and is
implicated in resistance to a number of the chemotherapeutic agents cu
rrently used in the treatment: of high-grade transitional cell carcino
ma (TCC) of the bladder (doxorubicin, epirubicin and vinblastine). Usi
ng a sensitive RT-PCR-based technique, we have quantified MRP mRNA lev
els in a series of untreated TCC (n = 24), normal bladder (n = 5) and
control tissue and cell line samples. MRP mRNA was widely expressed an
d detectable in all samples analysed, with considerable (up to 190-fol
d) variation observed between individual tumour samples. MRP mRNA leve
ls found in TCC samples were lower than those determined for normal pe
ripheral mononucleocyte (2.3-fold) and testis (4.1-fold) samples, prev
iously reported to be high-expressing tissues, and varied over a simil
ar range to that observed in normal bladder samples. Results indicate
that MRP mRNA levels in a greater proportion of high-grade (G3) bladde
r rumours (55%, 6/11) are significantly reduced (P = 0.018) compared w
ith low- and moderate-grade (G1/2) bladder tumours (8%, 1/13), and sug
gest that MRP mRNA levels frequently become reduced as a consequence o
f tumour progression to advanced, poorly differentiated disease. No co
rrelation was apparent between MRP and MDR1 mRNA levels, thus providin
g no evidence to suggest common regulation of the two genes. In a limi
ted number of patients, no evidence was found to support a role for MR
P mRNA levels as a determinant of response to chemotherapy in patients
being uniformly treated with either cisplatin-methotrexate-vinblastin
e (II = 6) or epirubicin- cisplatin-methotrexate (n = 4) regimens. Sim
ilarly, no overall pattern of altered MRP mRNA expression was observed
following chemotherapy in four patients from whom post chemotherapy b
iopsies were taken. This study provides a useful pilot investigation r
egarding the level, variation and pattern of MRP mRNA expression in TC
C of the bladder, and suggests that further studies to establish the c
linical significance of these variations are required.